Syros Pharmaceuticals, Inc. (SYRS)
NASDAQ: SYRS · IEX Real-Time Price · USD
6.27
+0.21 (3.47%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Syros Pharmaceuticals Market Cap
Syros Pharmaceuticals has a market cap or net worth of $167.59 million as of July 22, 2024. Its market cap has increased by 177.92% in one year.
Market Cap
167.59M
Enterprise Value
118.83M
1-Year Change
177.92%
Ranking
Category
Stock Price
$6.27
Market Cap Chart
Since June 30, 2016, Syros Pharmaceuticals's market cap has decreased from $413.10M to $167.59M, a decrease of -59.43%. That is a compound annual growth rate of -10.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 167.60M | 2.13% |
| Dec 29, 2023 | 164.10M | 126.03% |
| Dec 30, 2022 | 72.60M | -64.04% |
| Dec 31, 2021 | 201.90M | -59.38% |
| Dec 31, 2020 | 497.00M | 69.45% |
| Dec 31, 2019 | 293.30M | 56.43% |
| Dec 31, 2018 | 187.50M | -26.73% |
| Dec 29, 2017 | 255.90M | -9.99% |
| Dec 30, 2016 | 284.30M | -31.18% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Acumen Pharmaceuticals | 172.43M |
| OrganiGram Holdings | 170.56M |
| Rigel Pharmaceuticals | 169.61M |
| Adverum Biotechnologies | 169.58M |
| Atossa Therapeutics | 168.51M |
| Repare Therapeutics | 165.54M |
| Skye Bioscience | 165.32M |
| TruBridge | 163.73M |